Search research articles
Contact Us
Filters
Showing results (311-320 of 717) with videos related to
Page
of 72
Sort By:
Cardiovascular Diabetology
|
November 18, 2019
Differences in lipid metabolism between anagliptin and sitagliptin in patients with type 2 diabetes on statin therapy: a secondary analysis of the REASON trial
Atsuko Chihara, Atsushi Tanaka, Takeshi Morimoto, et al.
Journal of Cardiology
|
February 5, 2003
[Opening of ATP-sensitive potassium channel attenuates cardiac remodeling induced by chronic inhibition of nitric oxide synthesis]
Shoji Sanada, Koichi Node, Hiroshi Asanuma, et al.
Atherosclerosis
|
July 21, 2007
Pentraxin3 is a novel marker for stent-induced inflammation and neointimal thickening
Norihiko Kotooka, Teruo Inoue, Daisuke Fujimatsu, et al.
Atherosclerosis
|
January 20, 2007
Increased circulating platelet-derived microparticles are associated with stent-induced vascular inflammation
Teruo Inoue, Hiroshi Komoda, Norihiko Kotooka, et al.
Cardiovascular Intervention and Therapeutics
|
March 3, 2022
Antiplatelet therapy after percutaneous coronary intervention: current status and future perspectives
Masahiro Natsuaki, Shinjo Sonoda, Goro Yoshioka, et al.
Cardiovascular Diabetology
|
May 20, 2023
Lack of impact of ipragliflozin on endothelial function in patients with type 2 diabetes: sub-analysis of the PROTECT study
Shinji Kishimoto, Yukihito Higashi, Takumi Imai, et al.
Journal of Cardiology
|
June 8, 2007
Association between silent ST segment depression in exercise electrocardiography and insulin resistance in obese subjects
Ryoma Michishita, Naoko Shono, Akira Kiyonaga, et al.
Cardiovascular Diabetology
|
August 8, 2022
Association between serum insulin levels and heart failure-related parameters in patients with type 2 diabetes and heart failure treated with canagliflozin: a post-hoc analysis of the randomized CANDLE trial
Atsushi Tanaka, Takumi Imai, Michio Shimabukuro, et al.
Biomedicines
|
July 27, 2022
Comparing the Effects of Canagliflozin vs. Glimepiride by Body Mass Index in Patients with Type 2 Diabetes and Chronic Heart Failure: A Subanalysis of the CANDLE Trial
Akira Sezai, Atsushi Tanaka, Takumi Imai, et al.
Journal of Cardiology
|
November 30, 2016
Safety and efficacy of liraglutide treatment in Japanese type 2 diabetes patients after acute myocardial infarction: A non-randomized interventional pilot trial
Masataka Kajiwara, Atsushi Tanaka, Tomohiro Kawasaki, et al.
Page
of 72
Search research articles
Search
Showing results (311-320 of 717) with videos related to
Sort By:
Page
of 72
Cardiovascular Diabetology
|
November 18, 2019
Differences in lipid metabolism between anagliptin and sitagliptin in patients with type 2 diabetes on statin therapy: a secondary analysis of the REASON trial
Atsuko Chihara, Atsushi Tanaka, Takeshi Morimoto, et al.
Journal of Cardiology
|
February 5, 2003
[Opening of ATP-sensitive potassium channel attenuates cardiac remodeling induced by chronic inhibition of nitric oxide synthesis]
Shoji Sanada, Koichi Node, Hiroshi Asanuma, et al.
Atherosclerosis
|
July 21, 2007
Pentraxin3 is a novel marker for stent-induced inflammation and neointimal thickening
Norihiko Kotooka, Teruo Inoue, Daisuke Fujimatsu, et al.
Atherosclerosis
|
January 20, 2007
Increased circulating platelet-derived microparticles are associated with stent-induced vascular inflammation
Teruo Inoue, Hiroshi Komoda, Norihiko Kotooka, et al.
Cardiovascular Intervention and Therapeutics
|
March 3, 2022
Antiplatelet therapy after percutaneous coronary intervention: current status and future perspectives
Masahiro Natsuaki, Shinjo Sonoda, Goro Yoshioka, et al.
Cardiovascular Diabetology
|
May 20, 2023
Lack of impact of ipragliflozin on endothelial function in patients with type 2 diabetes: sub-analysis of the PROTECT study
Shinji Kishimoto, Yukihito Higashi, Takumi Imai, et al.
Journal of Cardiology
|
June 8, 2007
Association between silent ST segment depression in exercise electrocardiography and insulin resistance in obese subjects
Ryoma Michishita, Naoko Shono, Akira Kiyonaga, et al.
Cardiovascular Diabetology
|
August 8, 2022
Association between serum insulin levels and heart failure-related parameters in patients with type 2 diabetes and heart failure treated with canagliflozin: a post-hoc analysis of the randomized CANDLE trial
Atsushi Tanaka, Takumi Imai, Michio Shimabukuro, et al.
Biomedicines
|
July 27, 2022
Comparing the Effects of Canagliflozin vs. Glimepiride by Body Mass Index in Patients with Type 2 Diabetes and Chronic Heart Failure: A Subanalysis of the CANDLE Trial
Akira Sezai, Atsushi Tanaka, Takumi Imai, et al.
Journal of Cardiology
|
November 30, 2016
Safety and efficacy of liraglutide treatment in Japanese type 2 diabetes patients after acute myocardial infarction: A non-randomized interventional pilot trial
Masataka Kajiwara, Atsushi Tanaka, Tomohiro Kawasaki, et al.
Page
of 72